Prevalence and Risk Factors of Uterine Fibroids in North-East SloveniaTina Bizjak*, Anela Becic Turkanovic and Igor But
University Medical Centre Maribor, Department of General Gynaecology and Gynaecologic Urology, Maribor, Slovenia
- *Corresponding Author:
- Tina Bizjak
University Clinical Centre Maribor
Division of Gynecology and Perinatology
Ljubljanska 5, 2000 Maribor, Slovenia
Tel: +3862 321 2178
E-mail: [email protected]
Received date December 23, 2015; Accepted date January 18, 2016; Published date January 20, 2016
Citation: Bizjak T, Turkanovic AB, But I (2016) Prevalence and Risk Factors of Uterine Fibroids in North-East Slovenia. Gynecol Obstet (Sunnyvale) 6:350. doi:10.4172/2161-0932.1000350
Copyright: © 2016 Bizjak T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Objectives: Uterine fibroids are the most common pelvic tumors in women, occurring globally with a prevalence of 21.4%. The aim of this study is to reveal the prevalence of fibroids in a patient population from the municipality of Maribor, Slovenia, and to identify associated risk factors.
Methods: The study was based on a random sample of 2000 women within the age group of 25 to 56 living in the municipality of Maribor, Slovenia. Participation was completely voluntary. Eligible patients had to fill out a questionnaire and would undergo a transvaginal ultrasound. The data were processed with the statistical program PASW 18, and p values < 0.05 were taken to statistically significant differences.
Results: Nine hundred and twenty-one of the 2,000 women (46.1%) have responded to our invitation and uterine fibroids were identified in 21.1% of them. The prevalence of fibroids was statistically significantly lower (6.7%) in the younger group (25-35 years) than in the group aged 36-45 years (prevalence of 33.3%, χ2=34.4, p=0.0001) and that of 46-56 years (prevalence of 60%, χ2=53.7, p=0.0001). The prevalence of fibroids was higher in women who had never used oral contraceptives when compared to those who had (27.0% vs. 19.7%; χ2=4.8, p=0.028). Women with fibroids had a 1.2 kg/m2 (95% CI: 0.4-1.9) higher BMI (t=-3.0, p=0.003). Other previously described risk factors did not appear of significance.
Conclusion: Fibroids represent an important gynecologic pathology in women due to its relatively high prevalence and their probable impact on patient’s quality of life.